Browsing by Subject "HAART"
Now showing items 21-30 of 30
-
Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy
(CID, 2008)Background. Cryptococcal meningitis (CM) is the proximate cause of death in 20%–30% of persons with acquired immunodeficiency syndrome in Africa. Methods. Two prospective, observational cohorts enrolled human immunodeficiency ... -
Prevalence and associated factors of osteoporosis in HIV infected adults attending MU-JHU outpatient clinic at Mulago National Referral Hospital.
(Namusoke, J. (2014). Prevalence and associated factors of osteoporosis in HIV infected adults attending MU-JHU outpatient clinic at Mulago National Referral Hospital. Unpublished masters thesis. Makerere University, Kampala, Uganda., 2014)Introduction Western studies have described and noted an increased prevalence rate of osteoporosis in HIV infected patients. The causes of osteoporosis in this population appear to be multifactorial and likely represent ... -
Prevalence and factors associated with dual contraception among women living with HIV/AIDS attending TASO Mulago HIV Clinic.
(Makerere University, 2014-07)Introduction: Dual contraception refers to use of condom concurrently with another effective contraceptive method to prevent unwanted pregnancies and sexually transmitted diseases including HIV. With advent of HAART, HIV ... -
Prevalence, pattern and factors associated with liver enzyme elevation among HIV-infected patients admitted in Kiruddu National Referral Hospital
(Makerere University, 2022-12-18)Background: Globally, mortality and morbidity among Human Immunodeficiency Virus (HIV)-infected patients have tremendously improved over the years in this post- Highly Active Anti-retroviral Therapy (HAART) era. However, ... -
The role of depression in predicting antiretroviral adherence in Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: commentary on Jayne Byakika-Tusiime et al. 2009.
(Springer Verlag, 2009-08-07)Sub-Saharan Africa remains the region most heavily affected by HIV, accounting for 67% of all people living with HIV [1]. There remains a need for more comprehensive HIV treatment and prevention programs in this region. ... -
Rolling out antiretrovirals in Africa: there are still challenges ahead
(Infectious Diseases Society of America, 2005-08)In their article “Lessons Learned from Highly Active Antiretroviral Therapy in Africa,” Akileswaran et al. [1] review the effectiveness of HAART programs in Africa. They report positive health outcomes, including high ... -
Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda
(Makerere University Medical School, 2004-08)Introduction: Total Lymphocyte Count (TLC) has been found to be an inexpensive and useful marker for staging disease, predicting progression to AIDS and death and monitoring response to ART. However, the correlation between ... -
Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda
(Makerere University Medical School, 2004-08)Introduction: Total Lymphocyte Count (TLC) has been found to be an inexpensive and useful marker for staging disease, predicting progression to AIDS and death and monitoring response to ART. However, the correlation between ... -
Whole exome sequencing uncovers genetic predisposition to pediatric HIV disease progression and hyperhemolysis syndrome
(Makerere University, 2022-07)Background: Populations of African ancestry hold a disproportionate burden of infectious and non-infectious diseases. Genetic variants, with population allele frequencies ranging from rare to common variants, are believed ... -
Zinc status in HIV infected Ugandan children aged 1-5 years: a cross sectional baseline survey
(BioMed Central, 2010)Background: Low concentrations of serum zinc have been reported in HIV infected adults and are associated with disease progression and an increased risk of death. Few studies have been conducted in HIV infected children ...